logo

Beta Agonist Feed Additive Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The global beta-agonist feed additive market has been segmented by type into zilpaterol and ractopamine, and by animal type into ruminants, swine, and others. Also more than 10 major demographics registering considerable sales of beta-agonist feed additives during the study period have also been analyzed in the study scope.

Home Market Analysis Animal Nutrition & Wellness Research Feed Additives Research Beta-Agnostic Feed Additives Research Beta Agonist Feed Additive Market

Beta Agonist Feed Additives Market Size

Beta Agonist Feed Additive Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 2.80 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Beta Agonist Feed Additive Market Key players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Beta Agonist Feed Additive Market with other markets in Animal Nutrition & Wellness Industry

Compound Feed

Feed Additives

Pet Care

Animal Farm Services

Beta Agonist Feed Additives Market Analysis

The Global Beta Agonist Feed Additive Market is projected to grow at a CAGR of 2.8% during the forecast period (2020-2025). North America to dominate the beta-agonist feed additive market by garnering nearly 77% of the global sales in 2018. According to the US Department of Agriculture (USDA), the year 2018 set a record of 222.2 pounds per capita of animal meat being consumed in the United States, breaking the previous year's record of 216.9 pounds per capita. The growing consumption of meat is expected to stimulate the production of cattle, which in turn, may bolster the US beta-agonist feed additives market in the forecast period. 60-80% of the US fed cattle are raised with a beta-agonist, like Optaflexx (ractopamine hydrochloride) sold by Elanco Animal Health or Zilmax (zilpaterol hydrochloride) manufactured by Merck Animal Health. The increasing demand for animal meat, including ruminant and swine meat around the world, and the health benefits of beta-agonist feed additives are some of the major driving factors for the global beta-agonist feed additive market.

Beta Agonist Feed Additives Market Trends

This section covers the major market trends shaping the Beta Agonist Feed Additives Market according to our research experts:

Increasing Demand for Animal Meat to Boost the Beta Agonist Feed Additive Sales

There has been increasing pressure on the livestock industry, to meet the increasing demand for meat and high-value animal protein. Population growth, rising incomes in developing nations, and urbanization have led to a surge in global livestock production. The level of income and consumption of animal protein is directly related to the consumption of milk, meat, and eggs, which are increasing at the expense of staple foods. Due to a decline in the prices of meat and meat products, developing countries are beginning to consume large quantities of meat, at a much lower level of the gross domestic product than industrialized countries did, two to three decades back. Urbanization has led to increased demand for meat and milk products in cities when compared to the rural areas.

The global meat market has maintained its growth, and the global consumption of meat products is expected to witness a significant CAGR over the forecast period. The highest growth in meat consumption is expected from the Asia-Pacific and Latin American regions, because of changing diet patterns, urbanization, population, and economic growth. For example, Chinese demand for meat continues to surpass the domestic supply, according to Agriculture and Agri-food Canada.

Beta Agonist Feed Additive Market Trends

United States to Dominate the Beta Agonist Feed Additive Sales

The United States Market is projected to grow at a CAGR of 3.8% during the forecast period (2020-2025). Meat, particularly beef, is the centerpiece of the average American dinner. According to the US Department of Agriculture (USDA), the year 2018 set a record of 222.2 pounds per capita of animal meat being consumed in the United States, breaking the previous year's record of 216.9 pounds per capita.

The growing consumption of meat is expected to stimulate the production of cattle, which in turn, may bolster the US beta-agonist feed additives market in the forecast period. 60-80% of the US fed cattle are raised with a beta-agonist, like Optaflexx (ractopamine hydrochloride) sold by Elanco Animal Health or Zilmax (zilpaterol hydrochloride) manufactured by Merck Animal Health. However, in 2013, Merck Animal Health had halted the production of Zilmax, following which Tyson Foods, one of the largest processors of meat, also stopped purchasing the drug. The result of lesser production and usage of Zilmax has left a negative influence on the market. Since the time Zilmax was banned, Optaflexx has been performing well in the US market, accounting for the majority share of the beta-agonist feed additives market.

Beta Agonist Feed Additive Market Analysis

Beta Agonist Feed Additives Industry Overview

There are very few players, who offer beta-agonist feed additives, as most players in the market offer the same products and innovations, in terms of new products, and are anticipated to give a competitive advantage, thereby resulting in a very concentrated competitive spacing in the global beta-agonist feed additives market.

Beta Agonist Feed Additives Market Leaders

  1. Merck Animal Health

  2. Elanco Animal Health

  3. Zoetis

  4. Quality Liquid Feeds

  5. Heer Pharma Private Limited

*Disclaimer: Major Players sorted in no particular order

Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feeds, Heer Pharma Private Limited
Need More Details on Market Players and Competitors?
Download PDF

Beta Agonist Feed Additives Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions & Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Powers of Buyers

      2. 4.4.2 Bargaining Powers of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitutes

      5. 4.4.5 Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type

      1. 5.1.1 Ractopamine

      2. 5.1.2 Zilpaterol

    2. 5.2 Animal Type

      1. 5.2.1 Swine

      2. 5.2.2 Ruminants

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

        4. 5.3.1.4 Rest of North America

      2. 5.3.2 Asia-Pacific

        1. 5.3.2.1 Japan

        2. 5.3.2.2 South Korea

        3. 5.3.2.3 India

        4. 5.3.2.4 Rest of Asia-Pacific

      3. 5.3.3 South America

        1. 5.3.3.1 Brazil

        2. 5.3.3.2 Argentina

        3. 5.3.3.3 Rest of South America

      4. 5.3.4 Rest of the World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Most Adopted Strategies

    2. 6.2 Market Share Analysis

    3. 6.3 Company Profiles

      1. 6.3.1 Merck Animal Health

      2. 6.3.2 Elanco Animal Health

      3. 6.3.3 Zoetis

      4. 6.3.4 Quality Liquid Feeds

      5. 6.3.5 Heer Pharma Private Limited

    4. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

  8. 8. IMPACT OF COVID-19

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Beta Agonist Feed Additives Industry Segmentation

Beta-agonists feed additives are used to feed ruminants and swine, especially before slaughtering. They are approved feed additives, which help in escalating lean muscle gain, increase growth rate, and feed efficiency. The report presents an in-depth analysis of the market share, size, and trends of the global beta-agonist feed additive market. It comprises a comprehensive analysis of market segmentation on the basis of types of feed additives and animal types for which, feed additives are used.

Type
Ractopamine
Zilpaterol
Animal Type
Swine
Ruminants
Others
Geography
North America
United States
Canada
Mexico
Rest of North America
Asia-Pacific
Japan
South Korea
India
Rest of Asia-Pacific
South America
Brazil
Argentina
Rest of South America
Rest of the World
Need A Different Region Or Segment?
Customize Now

Beta Agonist Feed Additives Market Research FAQs

The Beta Agonist Feed Additive Market is projected to register a CAGR of 2.80% during the forecast period (2024-2029)

Merck Animal Health, Elanco Animal Health, Zoetis, Quality Liquid Feeds and Heer Pharma Private Limited are the major companies operating in the Beta Agonist Feed Additive Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Beta Agonist Feed Additive Market.

The report covers the Beta Agonist Feed Additive Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Beta Agonist Feed Additive Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Beta Agonist Feed Additive Industry Report

Statistics for the 2024 Beta Agonist Feed Additive market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. Beta Agonist Feed Additive analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Beta Agonist Feed Additive Report Snapshots

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Beta Agonist Feed Additive Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)